Financhill
Back

Protara Therapeutics Stock Predictions

Protara Therapeutics Stock Forecast

  • Is Protara Therapeutics Stock Undervalued?
    The current Protara Therapeutics [TARA] share price is $2.58. The Score for TARA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • TARA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Protara Therapeutics Stock Go Up Next Year?

Data Unavailable

Protara Therapeutics Stock Rating

Data Unavailable

Protara Therapeutics Stock Price History

Is TARA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protaratx.com

52-Week Data

52-Week High:
5.24
52-Week Low:
1.04

Prediction Charts

Market Cap:
53.22M
Price in USD:
2.58
Volume:
88.38K
Beta:
1.39

Technical Analysis

SMA50:
1.99
SMA100:
2.07
SMA200:
2.68
52-Wk Change:
116.81%

Stock Predictions

  • Is Protara Therapeutics stock public?
    Yes, Protara Therapeutics is a publicly traded company.
  • What is the Protara Therapeutics stock quote today?
    The Protara Therapeutics stock price is 2.58 USD today.
  • How to buy Protara Therapeutics stock online?
    You can buy Protara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 1.88 1.88 1.92 1.78
Oct-24 1.87 2.00 2.04 1.80
Oct-25 1.99 2.26 2.35 1.96
Oct-28 2.27 2.40 2.42 2.25
Oct-29 2.39 2.34 2.39 2.21
Oct-30 2.32 2.34 2.44 2.25
Oct-31 2.38 2.49 2.53 2.27
Nov-1 2.54 2.47 2.55 2.34
Nov-4 2.49 2.59 2.60 2.44
Nov-5 2.61 2.61 2.74 2.56
Nov-6 2.72 2.45 2.72 2.43
Nov-7 2.48 2.54 2.56 2.45
Nov-8 2.54 2.52 2.57 2.45
Nov-11 2.60 2.58 2.66 2.51

Protara Therapeutics Earnings

Data Unavailable

Protara Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.27 per share, and an increase next year of $0.02 per share.

* Protara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.